News
Quotient Clinical, a Centre of Excellence for 14C enabled clinical drug development, provides innovative human ADME solutions for oncology molecules and inhaled products
4 March 2013 – Quotient Clinical, a business unit of Quotient Bioresearch (“Quotient”), today announced the completion of three significant clinical programs that emphasise its world leading position in 14C enabled clinical drug development.